Abstract
Due to the recent approval of multiple agents for HER2-positive breast cancer, the American Society of Clinical Oncology has issued new guidelines for the treatment of metastatic disease and recommendations for managing patients whose disease has spread to the brain.
©2014 American Association for Cancer Research.
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Brain Neoplasms / secondary*
-
Brain Neoplasms / therapy*
-
Breast Neoplasms / genetics
-
Breast Neoplasms / therapy*
-
Drug Resistance, Neoplasm / drug effects
-
Drug Resistance, Neoplasm / radiation effects
-
Evidence-Based Medicine
-
Female
-
Humans
-
Practice Guidelines as Topic*
-
Radiotherapy
-
Receptor, ErbB-2 / genetics*
Substances
-
Antineoplastic Agents
-
ERBB2 protein, human
-
Receptor, ErbB-2